Liver health and drug processing: a new study on venglustat

NCT ID NCT05718258

First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 25 times

Summary

This study looked at how different levels of liver impairment affect the way the body handles a single dose of the drug venglustat. Researchers compared adults with mild, moderate, or severe liver problems to those with healthy livers. The goal was to understand safety and how the drug moves through the body, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC FUNCTION ABNORMAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • American Research Corporation Site Number : 8400005

    San Antonio, Texas, 78215, United States

  • Clinical Pharmacology of Miami Site Number : 8400002

    Miami, Florida, 33014, United States

  • Inland Empire Liver Foundation Site Number : 8400004

    Rialto, California, 92377, United States

  • Investigational Site Number : 2760001

    Kiel, 24105, Germany

  • Nucleus Network Site Number : 8400001

    Saint Paul, Minnesota, 55114, United States

  • Volunteer Research Group-NOCCR Site Number : 8400003

    Knoxville, Tennessee, 37920, United States

Conditions

Explore the condition pages connected to this study.